Star Imaging And Path LabShare price, financial results, shareholding and management
- Market cap
- ₹129 cr
- Stock P/E
- 6.7peers 19.8
- Book value
- ₹66.6
- Price to book
- 1.11
- EV / operating profit
- -
- Market cap to sales
- 1.46
- ROCE · FY26
- 25.9%
- ROE · FY26
- 23.5%
- ROE, 3-year average
- 36.9%
- Operating margin · FY26
- 37.0%peers 16.9%
- Sales growth, 3 years
- 15.1%
- Profit growth, 3 years
- 168.0%
- Debt to equity
- 0.18peers 0.22
- Borrowings
- ₹21 cr
- Interest cover
- 14.1×
- Cash from business / op. profit
- 70%
- Debtor days
- 206
- Pledged
- 0.00%
- Promoter holding
- 71.92%
- Change in promoter holding
- 0.00 pts
- Shareholders
- 773
- 52-week high / low
- ₹152 / ₹46
- Dividend yield
- 0.00%
- Face value
- ₹10
Tap or hover on any figure for what it means. Our arithmetic on reported figures, at the latest close.
newboard is reading this company's filings. Its plain description, key points, management and study will appear here soon; the figures below are worked out from what it has filed.
Star Imaging And Path Lab share price chart
Close on 6 Nov 2026 · 0.00% on the day · Vol 4,000
Daily prices to 6 Nov 2026, adjusted for splits and bonuses. Closing prices only: check the exchange for the live price.
Share price returns
To the close of 6 Nov 2026
- 1 month
- -1.5%
- 3 months
- -10.0%
- 6 months
- -13.5%
- 1 year
- -46.8%
- Traded a day, 20 days
- ₹0.09 cr
Business growth
Sales and net profit, from the reported results
| Sales | Profit | |
|---|---|---|
| FY26 on FY25 | +5% | +20% |
| 3 years, a year | +15% | +168% |
| Latest half, H2 FY26 | +6% | -8% |
Star Imaging And Path Lab revenue and profit growth
Half-yearly results · Profit and lossSales have grown steadily. Last year profit grew faster than sales, so the company kept more from each rupee of sales.
SME companies report every six months. In the latest half, sales were higher than in the same half a year before. Profit grew more slowly than sales, so each rupee of sales left a little less profit.
Star Imaging And Path Lab half-yearly results
SME companies report every six months · ₹ crore
| H1FY25 | H2FY25 | H1FY26 | H2FY26 | |
|---|---|---|---|---|
| Sales | 43 | 41 | 45.19 | 43.34 |
| Expenses | 31 | 24 | 27.92 | 27.34 |
| Operating profit | 12 | 17 | 17.27 | 16 |
| OPM | 27.0% | 41.0% | 38.2% | 37.0% |
| Interest | 1 | 1 | 1.30 | 1 |
| Depreciation | 2 | 3 | 2.85 | 3 |
| Profit before tax | 8 | 13 | 13.49 | 12.76 |
| Net profit | 6 | 10 | 10.03 | 9.23 |
Star Imaging And Path Lab profit and loss
Full years to March, FY22 to FY26 · ₹ crore, consolidated where reported
| FY22 | FY23 | FY24 | FY25 | FY26 | |
|---|---|---|---|---|---|
| Sales | 69 | 58 | 79 | 84 | 88.53 |
| Expenses | 54 | 52 | 55 | 54 | 55.53 |
| Operating profit | 15 | 6 | 23 | 29 | 33 |
| OPM | 21.0% | 10.0% | 30.0% | 35.0% | 37.0% |
| Other income | 0 | 0 | 1 | 0 | 1 |
| Interest | 2 | 2 | 3 | 3 | 2 |
| Depreciation | 4 | 3 | 5 | 5 | 6 |
| Profit before tax | 9 | 1 | 16 | 21 | 26.26 |
| Tax rate | 33.3% | 0.0% | 25.0% | 23.8% | 26.7% |
| Net profit | 6 | 1 | 12 | 16 | 19.25 |
| EPS ₹ | 41.93 | 3.87 | 82.80 | 11.80 | 11.07 |
| Dividend payout | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
The years to FY25 come rounded to the nearest crore in the source.
Earnings per share before FY23 is on the share count of that time, before later bonus or share issues, so it does not compare with the years after.
Star Imaging And Path Lab profitability
Margins and returns on capitalLast year the company kept about as much from each rupee of sales as the year before. It earns a high return on the money it uses.
Operating margin, every year
Per cent of sales kept before interest, depreciation and tax
| FY22 | FY23 | FY24 | FY25 | FY26 | |
|---|---|---|---|---|---|
| Operating margin | 21.0% | 10.0% | 30.0% | 35.0% | 37.0% |
| Tax rate | 33.3% | 0.0% | 25.0% | 23.8% | 26.7% |
| ROCE | · | 6.3% | 34.9% | 33.3% | 25.9% |
| ROE | · | 5.3% | 47.1% | 40.0% | 23.5% |
| Dividend payout | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Star Imaging And Path Lab debt and cash flow
Balance sheet · Cash flow · Working capitalThe company's own money, its net worth, has grown fast. It cut its borrowings last year. Its loans are smaller than its own money. Last year the business brought in more cash than it showed as profit. Customers take longer to pay than they did in FY24, which ties up more of the company's money in unpaid bills.
Bars below the line are cash going out.
Star Imaging And Path Lab balance sheet
At each 31 March · ₹ crore
| FY22 | FY23 | FY24 | FY25 | FY26 | |
|---|---|---|---|---|---|
| Equity capital | 2 | 2 | 2 | 14 | 17 |
| Reserves | 17 | 17 | 30 | 34 | 99 |
| Net worth | 19 | 19 | 32 | 48 | 116 |
| Borrowings | 30 | 27 | 31 | 33 | 21 |
| Other liabilities | 9 | 15 | 19 | 17 | 17 |
| Total liabilities | 58 | 61 | 82 | 98 | 154 |
| Fixed assets | 15 | 19 | 22 | 21 | 25 |
| Capital work in progress | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 |
| Other assets | 43 | 42 | 60 | 77 | 129 |
Star Imaging And Path Lab cash flow
₹ crore
| FY22 | FY23 | FY24 | FY25 | FY26 | |
|---|---|---|---|---|---|
| Cash from operations | 14 | 5 | 18 | -6 | 23 |
| Cash from investing | -4 | -7 | -7 | -4 | -13 |
| Cash from financing | -7 | -5 | 2 | 0 | 36 |
| Net cash flow | 3 | -7 | 13 | -10 | 46 |
Working capital
Days
| FY22 | FY23 | FY24 | FY25 | FY26 | |
|---|---|---|---|---|---|
| Debtor days | 85 | 110 | 152 | 222 | 206 |
| Inventory days | · | · | · | · | 24 |
| Days payable | · | · | · | · | 398 |
| Cash conversion cycle | 85 | 110 | 152 | 222 | -167 |
| Working capital days | 6 | -13 | 23 | 121 | 142 |
Star Imaging And Path Lab peers and competitors
Listed SME companies in the same industryBy sales, Star Imaging And Path Lab is number 7 of the 23 listed SME companies in healthcare services.
Each company's latest full year and its latest close; companies the exchange puts in the same industry, whose businesses can differ a good deal. A list, not a comparison of their shares.
| Company | Market cap ₹ cr | P/E | Sales ₹ cr | Profit ₹ cr | Op. margin | Debt/equity |
|---|---|---|---|---|---|---|
| Unihealth Hospitals | 943 | 36.5 | 132 | 25.8 | 40.8% | 0.15 |
| Sangani Hospitals | 88 | 29.4 | 107 | 3 | 7.6% | 0.04 |
| Hannah Joseph Hospital | 236 | 21.5 | 92 | 11 | 27.0% | 0.28 |
| Nephro Care India | 141 | 41.9 | 88.7 | 3.4 | 9.4% | 0.00 |
| Star Imaging And Path Lab | 129 | 6.7 | 88.5 | 19.3 | 37.0% | 0.18 |
| Modern Diagnostic & Research Centre | 95 | 18.1 | 83.1 | 5.3 | 15.4% | 0.63 |
| Pramodini Medicare | 254 | 15.0 | 62 | 17 | 50.0% | 0.34 |
| Adeshwar Meditex | - | - | 56.1 | 1.3 | 4.9% | 0.16 |
| ABH Healthcare | 52 | 9.3 | 51.6 | 5.6 | 28.8% | 3.17 |
| Shanmuga Hospital | 57 | 13.4 | 45 | 4.2 | 18.4% | 0.16 |
| Maitreya Medicare | 80 | - | 44.9 | -2.5 | -0.7% | 0.80 |
| Median of the 10 others | 95 | 19.8 | 72.6 | 4.7 | 16.9% | 0.22 |
Star Imaging And Path Lab shareholding pattern
Promoters, FIIs, DIIs, HNIs and small holdersThe promoters own more than half the company. Big foreign and Indian funds own very little. The number of shareholders is about the same.
Star Imaging And Path Lab shareholding pattern
Per cent of shares, from the patterns filed with the exchange. Tap + to see everyone holding 1% or more in that group. HNIs and small holders show only where the pattern was filed in full.
| Sep 25 | Mar 26 | |
|---|---|---|
| Promoters | 71.92% | 71.92% |
| Foreign investors (FIIs) | 1.37% | - |
| Indian institutions (DIIs) | 9.33% | - |
| Number of shareholders | 779 | 773 |
Star Imaging And Path Lab latest news and announcements
Announcements · Documents · Corporate actionsWhat changed recently
Each half-year is set against the same half a year earlier
- H2 FY26: sales ₹43.3 cr (+6%), net profit ₹9.2 cr (-8%) on H2 FY25.
- Shareholding, 31 March 2026: promoters unchanged at 71.92%.
Star Imaging And Path Lab announcements
5 on record, latest first; each opens the filing on the exchange
- Company UpdateCompliance Certificate as per Regulation 74(5) of SEBI ( Depositories and Participants) Regulations, 2018 for the Quarter ended 30th September 2026PDF ↗
- AGM/EGMVoting Result and Scrutinizer report for the 22nd Annual General Meeting of Star Imaging and Path Lab Limited held on 29th September 2026PDF ↗
- AGM/EGMSummary of proceeding of 22nd Annual General Meeting (AGM) of Star Imaging and Path Lab Limited held on Tuesday 29th September 2026PDF ↗
- Company UpdateCT Scan Facility at R G Stone Hospital Faridabad , HaryanaPDF ↗
- Insider Trading / SASTIntimation of Closure of Trading Window for Declaration of Unaudited Financial Results for the Half Year Ended 30th September 2026PDF ↗
Star Imaging And Path Lab annual reports, earnings calls and documents
Every document links to its source; “read” marks those this page is built from
Star Imaging And Path Lab share split, bonus and dividends
From the corporate actions the company announces on the exchange
No share split, bonus issue or dividend is on record since listing.
Checks we ran on Star Imaging And Path Lab's data · 8
Before any number shows, it goes through the same checks. A figure that fails is held back, never shown as if it were right.
- ✓Balance sheet totals add up for FY25 and FY26.
- ✓Market cap uses the share count in the latest shareholding pattern (1,74,20,000 shares).
- ✓The share capital in the FY26 results matches the share count in the shareholding pattern.
- ✓Promoter and public holdings add up to 100% in every shareholding pattern shown.
- ✓The two half-years of FY26 add up to the full-year sales.
- !Earnings per share changes basis between FY24 (₹82.80) and FY25 (₹11.80) because the share count behind it changes; EPS is shown as reported, and growth is worked out on profit.
- ✓Revenue and profit are reported for every year shown, FY22 to FY26.
- iPrices run to the close on 14 Oct 2026, from the exchange's daily figures.
Questions people ask about Star Imaging And Path Lab
What does Star Imaging And Path Lab do?
Star Imaging And Path Lab is an SME company listed on BSE SME, in healthcare services.
What is the share price of Star Imaging And Path Lab?
₹74 at the close on 6 Nov 2026, from the exchange's daily figures.
What is the market cap of Star Imaging And Path Lab?
₹129 cr at the close on 6 Nov 2026, on 1,74,20,000 shares.
What is the P/E of Star Imaging And Path Lab?
6.7 times FY26 profit at the close on 6 Nov 2026 (our arithmetic).
What are Star Imaging And Path Lab's revenue and profit?
Revenue ₹89 cr and profit after tax ₹19 cr in FY26.
Who are the promoters of Star Imaging And Path Lab?
The promoter group; promoters held 71.92% at 31 March 2026.
What is Star Imaging And Path Lab's website?
www.starimaging.in
More SME companies like Star Imaging And Path Lab
Other listed SME companies in healthcare services, the closest in size first, each read from its own documents.
- Nephro Care IndiaNEPHROCARE · NSE Emerge · Healthcare Services · listed 2024Market cap ₹126 cr
- Invicta DiagnosticINVICTA · NSE Emerge · Healthcare Services · listed 2025Market cap ₹87 cr
- Modern Diagnostic & Research CentreMDRC · BSE SME · Healthcare ServicesMarket cap ₹83 cr
- Maitreya MedicareMAITREYA · NSE Emerge · Healthcare Services · listed 2023Market cap ₹83 cr
- Sangani HospitalsSANGANI · NSE Emerge · Healthcare Services · listed 2023Market cap ₹81 cr
- Aashka HospitalsAASHKA · BSE SME · Healthcare ServicesMarket cap ₹224 cr
Built from 5 exchange announcements, 2 shareholding patterns and 5 years of reported results. Every figure carries its source; where the documents are silent, the page says so.